Literature DB >> 24096866

X-linked deafness-2 (DFNX2) phenotype associated with a paracentric inversion upstream of POU3F4.

Gregory J Anger, Susan Crocker, Kyle McKenzie, Kerry K Brown, Cynthia C Morton, Karen Harrison, Jennifer J MacKenzie.   

Abstract

PURPOSE: The authors report on a 7-year-old male, designated FR, who has severe sensorineural hearing loss. Features include a round face, hypertelorism, epicanthal folds, and flat nasal root. Although there were early developmental concerns regarding FR, all but his speech delay resolved when he was placed in an educational program that accommodated his hearing loss. Genetic studies were performed to investigate genetic causes for his hearing loss.
METHOD: History, physical examination, audiologic assessment, and imaging were performed according to usual practice. FMR1,GJB2,GJB6, and POU3F4 genes were sequenced. Chromosomal studies consisted of karyotyping and breakpoint analysis by fluorescence in situ hybridization (FISH).
RESULTS: Results from FMR1,GJB2,GJB6, and POU3F4 sequencing and echocardiography, electrocardiogram, and abdominal ultrasound were normal. A computed tomography (CT) scan revealed a large fundus of the internal auditory canals and absence of the bony partition between the fundus and the adjacent cochlear turns, with a widened modiolus bilaterally. FR's CT findings were consistent with those described in persons with X-linked deafness-2 (DFNX2) hereditary deafness. FR's karyotype was 46,inv(X)(q13q24),Y.ish inv(X)(XIST+)mat. FISH refined the breakpoints to inv(X)(q21.1q22.3). The Xq21.1 breakpoint was narrowed to a 25-kb region 450 kb centromeric to the DFNX2 gene, POU3F4. There are rare case reports of DFNX2 patients with chromosomal rearrangements positioned centromeric to POU3F4 and no mutations within the gene.
CONCLUSION: Authors hypothesized that FR's hearing loss was caused by dysregulation of POU3F4 due to separation from regulatory elements affected by the inversion.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24096866      PMCID: PMC4644427          DOI: 10.1044/1059-0889(2013/13-0018)

Source DB:  PubMed          Journal:  Am J Audiol        ISSN: 1059-0889            Impact factor:   1.493


  15 in total

1.  Gene expression in normal and abnormal inner ears.

Authors:  A F Ryan; E B Crenshaw; D M Simmons
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

2.  Molecular analysis of the POU3F4 gene in patients with clinical and radiographic evidence of X-linked mixed deafness with perilymphatic gusher.

Authors:  R A Friedman; Y Bykhovskaya; G Tu; J M Talbot; D F Wilson; L S Parnes; N Fischel-Ghodsian
Journal:  Ann Otol Rhinol Laryngol       Date:  1997-04       Impact factor: 1.547

3.  Identification of a hot spot for microdeletions in patients with X-linked deafness type 3 (DFN3) 900 kb proximal to the DFN3 gene POU3F4.

Authors:  Y J de Kok; E R Vossenaar; C W Cremers; N Dahl; J Laporte; L J Hu; D Lacombe; N Fischel-Ghodsian; R A Friedman; L S Parnes; P Thorpe; M Bitner-Glindzicz; H J Pander; H Heilbronner; J Graveline; J T den Dunnen; H G Brunner; H H Ropers; F P Cremers
Journal:  Hum Mol Genet       Date:  1996-09       Impact factor: 6.150

4.  The brain-specific POU-box gene Brn4 is a sex-linked transcription factor located on the human and mouse X chromosomes.

Authors:  P J Douville; S Atanasoski; A Tobler; A Fontana; M E Schwab
Journal:  Mamm Genome       Date:  1994-03       Impact factor: 2.957

5.  Clinical features of female heterozygotes in the X-linked mixed deafness syndrome (with perilymphatic gusher during stapes surgery).

Authors:  C W Cremers; P L Huygen
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1983-11       Impact factor: 1.675

6.  A duplication/paracentric inversion associated with familial X-linked deafness (DFN3) suggests the presence of a regulatory element more than 400 kb upstream of the POU3F4 gene.

Authors:  Y J de Kok; G F Merkx; S M van der Maarel; I Huber; S Malcolm; H H Ropers; F P Cremers
Journal:  Hum Mol Genet       Date:  1995-11       Impact factor: 6.150

7.  RHS2, a POU domain-containing gene, and its expression in developing and adult rat.

Authors:  C Le Moine; W S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

8.  Further mutations in Brain 4 (POU3F4) clarify the phenotype in the X-linked deafness, DFN3.

Authors:  M Bitner-Glindzicz; P Turnpenny; P Höglund; H Kääriäinen; E M Sankila; S M van der Maarel; Y J de Kok; H H Ropers; F P Cremers; M Pembrey
Journal:  Hum Mol Genet       Date:  1995-08       Impact factor: 6.150

9.  Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4.

Authors:  Y J de Kok; S M van der Maarel; M Bitner-Glindzicz; I Huber; A P Monaco; S Malcolm; M E Pembrey; H H Ropers; F P Cremers
Journal:  Science       Date:  1995-02-03       Impact factor: 47.728

10.  A new mutation in the POU3F4 gene in a Japanese family with X-linked mixed deafness (DFN3).

Authors:  H Hagiwara; Y Tamagawa; K Kitamura; K Kodera
Journal:  Laryngoscope       Date:  1998-10       Impact factor: 3.325

View more
  8 in total

1.  De novo mutation in X-linked hearing loss-associated POU3F4 in a sporadic case of congenital hearing loss.

Authors:  Hideaki Moteki; A Eliot Shearer; Shuji Izumi; Yamato Kubota; Hela Azaiez; Kevin T Booth; Christina M Sloan; Diana L Kolbe; Richard J H Smith; Shin-Ichi Usami
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-03-19       Impact factor: 1.547

2.  Estrogen-related receptor gamma implicated in a phenotype including hearing loss and mild developmental delay.

Authors:  Samantha Lp Schilit; Benjamin B Currall; Ruen Yao; Carrie Hanscom; Ryan L Collins; Vamsee Pillalamarri; Dong-Young Lee; Tammy Kammin; Cinthya J Zepeda-Mendoza; Tarja Mononen; Lisa S Nolan; James F Gusella; Michael E Talkowski; Jun Shen; Cynthia C Morton
Journal:  Eur J Hum Genet       Date:  2016-07-06       Impact factor: 4.246

3.  Study of complex structural variations of X-linked deafness-2 based on single-molecule sequencing.

Authors:  Yi Jiang; Lihua Wu; Shasha Huang; Pidong Li; Bo Gao; Yongyi Yuan; Siwen Zhang; Guoliang Yu; Yong Gao; Hao Wu; Pu Dai
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

Review 4.  Human inversions and their functional consequences.

Authors:  Marta Puig; Sònia Casillas; Sergi Villatoro; Mario Cáceres
Journal:  Brief Funct Genomics       Date:  2015-05-20       Impact factor: 4.241

5.  Phenotypic and genetic characterization of a family carrying two Xq21.1-21.3 interstitial deletions associated with syndromic hearing loss.

Authors:  Sandra Iossa; Valerio Costa; Virginia Corvino; Gennaro Auletta; Luigi Barruffo; Stefania Cappellani; Carlo Ceglia; Giovanni Cennamo; Adamo Pio D'Adamo; Alessandra D'Amico; Nilde Di Paolo; Raimondo Forte; Paolo Gasparini; Carla Laria; Barbara Lombardo; Rita Malesci; Andrea Vitale; Elio Marciano; Annamaria Franzè
Journal:  Mol Cytogenet       Date:  2015-03-20       Impact factor: 2.009

6.  Genetic findings of Sanger and nanopore single-molecule sequencing in patients with X-linked hearing loss and incomplete partition type III.

Authors:  Ying Chen; Jiajun Qiu; Yingwei Wu; Huan Jia; Yi Jiang; Mengda Jiang; Zhili Wang; Hai-Bin Sheng; Lingxiang Hu; Zhihua Zhang; Zhaoyan Wang; Yun Li; Zhiwu Huang; Hao Wu
Journal:  Orphanet J Rare Dis       Date:  2022-02-21       Impact factor: 4.123

7.  The Burden and Benefits of Knowledge: Ethical Considerations Surrounding Population-Based Newborn Genome Screening for Hearing.

Authors:  Calli O Mitchell; Greysha Rivera-Cruz; Matthew Hoi Kin Chau; Zirui Dong; Kwong Wai Choy; Jun Shen; Sami Amr; Anne B S Giersch; Cynthia C Morton
Journal:  Int J Neonatal Screen       Date:  2022-05-27

8.  Position effect, cryptic complexity, and direct gene disruption as disease mechanisms in de novo apparently balanced translocation cases.

Authors:  Constantia Aristidou; Athina Theodosiou; Mads Bak; Mana M Mehrjouy; Efthymia Constantinou; Angelos Alexandrou; Ioannis Papaevripidou; Violetta Christophidou-Anastasiadou; Nicos Skordis; Sophia Kitsiou-Tzeli; Niels Tommerup; Carolina Sismani
Journal:  PLoS One       Date:  2018-10-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.